• Topics

  • Formats

Connecting experts in biology & chemistry to advance small molecule drug discovery

Explore Discovery US 2024: Fast-Tracking Novel Target Identification & Validation

As recent technological and pharmacological advances tackle the previously ‘undruggable’, Discovery US returns to support the discovery of novel pharmaceutical modalities beyond the rule of five – including novel degraders, molecular glues, orally-available peptides and radioligands.

The focussed, two-day agenda showcases the key platforms and technologies impacting early drug pipelines, from DNA-encoded libraries and phenotypic screening through to AI algorithms and organoid models. It brings together experts in target discovery and validation from across small & large biopharma organizations to discuss how the newest therapeutic paradigms can overcome historic challenges in drug development and provide optimized, novel drug candidates. Further sessions explore the use of automation to augment drug development and improve your lab productivity, showcasing the competitive advantages that can be gained in drug development through digitalization and robotics.

Benefit from our revamped programme for 2024, designed to provide in-depth discussion of the key technologies, modalities & platforms transforming small molecule drug discovery
Discover emerging drug targets beyond the rule of five, from Induced Proximity & Molecular Glues through to siRNAs and orally-available peptides, with case studies on the chemical & biological considerations of developing these complex molecules
Enable your lab to operate at peak productivity. Maximize your R&D capabilities with integration of advanced robotics & automation, as well as utilizing AI to augment your drug development

Agenda at a Glance

  • Day One | Track 1: Novel Targets Beyond The Rule Of Fives
  • Day One | Track 2: Novel Models For ADME-Tox Research & Disease Modelling
  • Day One | Track 3: Augmenting R&D With AI and Automation
  • Day Two | Track 1: Innovative Technologies For Hit Identification & Screening
  • Day Two | Track 2: Computational & Medicinal Chemistry
  • Day Two | Track 3: Genomics-Driven Drug Discovery & Bioinformatics
Available Dates

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?